An open label, prospective, age descending, randomized, two arm, single blind, parallel, active controlled, multicentre, non-inferiority, phase II/III clinical study to evaluate the immunogenicity and safety of Tetanus vaccine (adsorbed) of M/s BioVaccines (India) Pvt. Ltd. compared to Tetanus vaccine (adsorbed) of M/s Serum Institute of India Limited in healthy subjects aged 10-60 years of age - TT Phase III trial
Latest Information Update: 04 Jul 2019
At a glance
- Drugs Tetanus toxoid vaccine Biovaccines (Primary)
- Indications Tetanus
- Focus Registrational; Therapeutic Use
- Sponsors Bio Vaccines
- 13 Nov 2018 New trial record